• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过调节 p53 和 mTOR 信号通路,SIK1 和 SIK3 同工型在乳腺癌的有氧糖酵解和细胞生长中发挥独特作用。

Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.

机构信息

Cell Signaling and Cancer Biology Laboratory, Department of Biochemistry, Guindy Campus, University of Madras, Chennai 600025, India.

Cell Signaling and Cancer Biology Laboratory, Department of Biochemistry, Guindy Campus, University of Madras, Chennai 600025, India.

出版信息

Biochim Biophys Acta Mol Cell Res. 2021 Apr;1868(5):118975. doi: 10.1016/j.bbamcr.2021.118975. Epub 2021 Feb 2.

DOI:10.1016/j.bbamcr.2021.118975
PMID:33545220
Abstract

The Salt-inducible kinase (SIKs) belongs to an AMPK-related family kinase, an isoform of the SIK family, SIK1 gets frequently downregulated in various types of cancer contribute to tumorigenesis. However, its precise role in breast cancer and the relevant molecular mechanism remains unclear. Herein, analysis of the clinical data reveals that SIK1 expression was significantly downregulated in breast cancer tissues, and closely associated with poor survival rate in breast cancer. SIK1 is functionally stimulating oxidative phosphorylation, which in turn inhibits aerobic glycolysis and cell proliferation in breast cancer cells. Mechanistically, SIK1 directly interacted with p53 and positively regulates its transcriptional activity, thereby facilitates oxidative phosphorylation in breast cancer cells. The knockdown of SIK1 downregulates p53 transcriptional activity, leading to stimulation of aerobic glycolysis and cell proliferation. Moreover, high expression of SIK3 stimulates mTOR-mediated aerobic glycolysis and cell proliferation of breast cancer cells. These findings suggest that SIK isoforms plays distinct role in aerobic glycolysis and cell growth of breast cancer, attenuated SIK1/p53 signaling suppresses oxidative phosphorylation and growth inhibitory effect in breast cancer cells, while enhanced SIK3/mTOR signaling potentiates aerobic glycolysis mediated cell growth in breast cancer cells.

摘要

盐诱导激酶(SIKs)属于 AMPK 相关家族激酶,SIK 家族的一种同工酶,SIK1 在各种类型的癌症中经常下调,有助于肿瘤发生。然而,其在乳腺癌中的确切作用及其相关的分子机制尚不清楚。在此,临床数据分析表明 SIK1 在乳腺癌组织中表达明显下调,并与乳腺癌的生存率密切相关。SIK1 具有促进氧化磷酸化的功能,这反过来又抑制乳腺癌细胞中的有氧糖酵解和细胞增殖。在机制上,SIK1 直接与 p53 相互作用并正向调节其转录活性,从而促进乳腺癌细胞中的氧化磷酸化。SIK1 的敲低会降低 p53 的转录活性,导致有氧糖酵解和细胞增殖的刺激。此外,SIK3 的高表达会刺激 mTOR 介导的乳腺癌细胞中的有氧糖酵解和细胞增殖。这些发现表明 SIK 同工酶在乳腺癌的有氧糖酵解和细胞生长中发挥不同的作用,减弱的 SIK1/p53 信号抑制乳腺癌细胞中的氧化磷酸化和生长抑制作用,而增强的 SIK3/mTOR 信号增强乳腺癌细胞中由有氧糖酵解介导的细胞生长。

相似文献

1
Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.通过调节 p53 和 mTOR 信号通路,SIK1 和 SIK3 同工型在乳腺癌的有氧糖酵解和细胞生长中发挥独特作用。
Biochim Biophys Acta Mol Cell Res. 2021 Apr;1868(5):118975. doi: 10.1016/j.bbamcr.2021.118975. Epub 2021 Feb 2.
2
MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.MARK2 通过调节 mTOR/HIF-1α 和 p53 通路促进乳腺癌有氧糖酵解介导的细胞生长。
J Cell Biochem. 2022 Apr;123(4):759-771. doi: 10.1002/jcb.30219. Epub 2022 Jan 19.
3
Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway.小檗碱和大黄素通过抑制 SIK3 诱导的 mTOR 和 Akt 信号通路来抑制乳腺癌生长并促进细胞凋亡。
Biochim Biophys Acta Mol Basis Dis. 2020 Nov 1;1866(11):165897. doi: 10.1016/j.bbadis.2020.165897. Epub 2020 Jul 16.
4
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.AMPK 相关激酶 SIK1 和 SIK3 介导 LKB1 在 NSCLC 中的关键肿瘤抑制作用。
Cancer Discov. 2019 Nov;9(11):1606-1627. doi: 10.1158/2159-8290.CD-18-1261. Epub 2019 Jul 26.
5
Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.抑制有氧糖酵解可抑制Akt/mTOR/HIF-1α轴并恢复抗雌激素耐药乳腺癌细胞对他莫昔芬的敏感性。
PLoS One. 2015 Jul 9;10(7):e0132285. doi: 10.1371/journal.pone.0132285. eCollection 2015.
6
p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.p53/乳酸脱氢酶 A 轴负调控表达野生型 p53 的乳腺癌细胞中的有氧糖酵解和肿瘤进展。
Cancer Sci. 2019 Mar;110(3):939-949. doi: 10.1111/cas.13928. Epub 2019 Jan 31.
7
Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.盐诱导激酶2和-3在肥胖或胰岛素抵抗个体的脂肪组织中表达下调:对人脂肪细胞中胰岛素信号传导和葡萄糖摄取的影响。
Diabetologia. 2017 Feb;60(2):314-323. doi: 10.1007/s00125-016-4141-y. Epub 2016 Nov 2.
8
The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer.盐诱导激酶(SIK)在癌症中具有多样的致癌和肿瘤抑制作用。
Expert Opin Ther Targets. 2016;20(4):477-85. doi: 10.1517/14728222.2016.1101452. Epub 2015 Nov 7.
9
Mutant p53 and mTOR/PKM2 regulation in cancer cells.癌细胞中的突变型p53与mTOR/PKM2调控
IUBMB Life. 2016 Sep;68(9):722-6. doi: 10.1002/iub.1534. Epub 2016 Jul 7.
10
SIKs suppress tumor function and regulate drug resistance in breast cancer.盐诱导激酶抑制乳腺癌的肿瘤功能并调节耐药性。
Am J Cancer Res. 2021 Jul 15;11(7):3537-3557. eCollection 2021.

引用本文的文献

1
Polyamine metabolism related gene index prediction of prognosis and immunotherapy response in breast cancer.乳腺癌中多胺代谢相关基因指标对预后及免疫治疗反应的预测
Front Oncol. 2025 Jul 31;15:1613458. doi: 10.3389/fonc.2025.1613458. eCollection 2025.
2
miR-17-5p is highly expressed in patients with lung cancer and promoted lung cancer by targeting SIK1.miR-17-5p在肺癌患者中高表达,并通过靶向SIK1促进肺癌发生。
Discov Oncol. 2025 Jun 4;16(1):1002. doi: 10.1007/s12672-025-02564-6.
3
SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation through the CRTC2/CREB1 signaling.
SIK1通过CRTC2/CREB1信号传导抑制白细胞介素-1β刺激的软骨细胞凋亡和炎症。
Open Life Sci. 2025 Mar 6;20(1):20221016. doi: 10.1515/biol-2022-1016. eCollection 2025.
4
EFHD1 Activates SIK3 to Limit Colorectal Cancer Initiation and Progression via the Hippo Pathway.EFHD1通过Hippo信号通路激活SIK3以限制结直肠癌的起始和进展。
J Cancer. 2025 Jan 20;16(4):1348-1362. doi: 10.7150/jca.103229. eCollection 2025.
5
Staphylococcus aureus blocks host autophagy through circSyk/miR-5106/Sik3 axis to promote progression of bone infection.金黄色葡萄球菌通过circSyk/miR-5106/Sik3轴阻断宿主自噬,以促进骨感染进展。
PLoS Pathog. 2025 Jan 27;21(1):e1012896. doi: 10.1371/journal.ppat.1012896. eCollection 2025 Jan.
6
Role of SIK1 in tumors: Emerging players and therapeutic potentials (Review).SIK1 在肿瘤中的作用:新兴的参与者和治疗潜力(综述)。
Oncol Rep. 2024 Dec;52(6). doi: 10.3892/or.2024.8828. Epub 2024 Oct 18.
7
Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.泛素特异性蛋白酶 54 通过调节 GLUT1 介导的有氧糖酵解来抑制肺腺癌的进展,其方式为修饰 p53 的降解。
Oncogene. 2024 Jun;43(26):2025-2037. doi: 10.1038/s41388-024-03047-8. Epub 2024 May 14.
8
UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma.UBE2C通过调节p53的表达来诱导胶质瘤中的有氧糖酵解,从而增强对替莫唑胺的耐药性。
Acta Biochim Biophys Sin (Shanghai). 2024 Jun 25;56(6):916-926. doi: 10.3724/abbs.2024033.
9
Deficiency of salt-inducible kinase 2 (SIK2) promotes immune injury by inhibiting the maturation of lymphocytes.盐诱导激酶2(SIK2)缺乏通过抑制淋巴细胞成熟促进免疫损伤。
MedComm (2020). 2023 Sep 11;4(5):e366. doi: 10.1002/mco2.366. eCollection 2023 Oct.
10
Roles of salt‑inducible kinases in cancer (Review).盐诱导激酶在癌症中的作用(综述)。
Int J Oncol. 2023 Nov;63(5). doi: 10.3892/ijo.2023.5566. Epub 2023 Sep 1.